Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1996
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0742720A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136279A Extract from the leaves of gingko biloba
11/20/1996CN1136278A Combination of bisphosphonates and growth hormone secretagogues
11/19/1996US5576353 Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
11/19/1996US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
11/19/1996US5575652 Process for applying antibacterial oral composition to dental implant areas
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035950A1 Inhibition of amylin release
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035453A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy
11/14/1996WO1996035452A1 Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders
11/14/1996WO1996035446A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035429A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996WO1996035417A1 Combinations of anti-oestrogen compounds and pkc modulators and their use in cancer therapy
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/14/1996WO1996035415A2 Use of sesquiterpenes for inhibiting oxidative enzymes
11/14/1996WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/14/1996DE19518221A1 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen Use of non-steroidal anti-inflammatory drugs to improve the physiological tolerance particulate pharmaceutical preparations
11/14/1996CA2220897A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220677A1 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
11/14/1996CA2220106A1 Inhibition of amylin release
11/14/1996CA2220052A1 Use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741575A1 Human therapeutic uses of bpi protein products
11/13/1996EP0741574A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
11/13/1996EP0741568A1 Inhibition of arthritis by l-type calcium channel antagonists
11/13/1996CN1135715A Novel composition
11/12/1996US5574205 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/12/1996US5574067 Method of treating wrinkles using gluconic acid or gluconolactone
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996US5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
11/12/1996CA1338702C High drug:lipid formulations of liposomal- antineoplastic agents
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996WO1996034599A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996DE4447287C1 Droplet-in-fluid composition to transport agent e.g. through skin
11/07/1996CA2220180A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/06/1996EP0740940A2 Process for disinfecting musculoskeletal tissue and tissues prepared thereby
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740650A1 Codrugs as a method of controlled drug delivery
11/06/1996EP0740551A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors
11/06/1996EP0740549A1 Cis-hydroxyproline analogs for eye treatment
11/06/1996CN1135178A Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor
11/06/1996CN1135176A Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio-and post menopausal women
11/05/1996US5571841 Treating skin with mandelic acid for wrinkle reduction
11/05/1996US5571837 Method of treating wrinkles using saccharic acid or saccharolactone
11/05/1996US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases
11/05/1996US5571827 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
11/05/1996US5571823 Pharmacological treatment of ocular development
11/05/1996US5571523 Antioxidant-induced apoptosis in vascular smooth muscle cells
11/05/1996US5571441 Nutrient supplement compositions providing physiologic feedback
11/05/1996US5570683 Methods and devices for treating pulmonary vasoconstriction and asthma
10/1996
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996033745A1 Formulations for lipophilic compounds
10/31/1996WO1996033740A1 Use of leukemia inhibitory factor and endothelin antagonists
10/31/1996WO1996033732A1 Multimeric, recombinant urease vaccine
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033726A1 Preparation and use of sulfated oligosaccharides
10/31/1996WO1996033724A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996WO1996033719A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/31/1996WO1996033717A1 Therapeutic composition for arthritis
10/31/1996WO1996033710A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist
10/31/1996WO1996033709A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines
10/31/1996WO1996033708A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996WO1996033705A1 Methods and formulations for modulating the human sexual response
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996033696A1 Novel collagen formulations
10/31/1996WO1996027384A3 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
10/31/1996CA2219226A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996CA2219201A1 Multimeric, recombinant urease vaccine
10/31/1996CA2218955A1 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
10/31/1996CA2218181A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist
10/31/1996CA2218037A1 Novel collagen formulations
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996CA2216138A1 Therapeutic composition for arthritis
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
10/30/1996CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
10/30/1996CN1134663A New emulsion formulation
10/29/1996US5569452 Pharmaceutical formulation having enhanced bile acid binding affinity
10/24/1996WO1996033416A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033268A1 Apopain
1 ... 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 ... 1151